This paper is in the following e-collection/theme issue:

Research Instruments, Questionnaires, and Tools (576) Breast Cancer (206)

Published on in Vol 19, No 9 (2017): September

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial

Authors of this article:

Markus Wallwiener1 Author Orcid Image ;   Lina Matthies1 Author Orcid Image ;   Elisabeth Simoes2 Author Orcid Image ;   Lucia Keilmann1 Author Orcid Image ;   Andreas D Hartkopf3 Author Orcid Image ;   Alexander N Sokolov2 Author Orcid Image ;   Christina B Walter3 Author Orcid Image ;   Nina Sickenberger1 Author Orcid Image ;   Stephanie Wallwiener1 Author Orcid Image ;   Manuel Feisst4 Author Orcid Image ;   Paul Gass5 Author Orcid Image ;   Peter A Fasching5 Author Orcid Image ;   Michael P Lux5 Author Orcid Image ;   Diethelm Wallwiener3 Author Orcid Image ;   Florin-Andrei Taran3 Author Orcid Image ;   Joachim Rom1 Author Orcid Image ;   Andreas Schneeweiss1 Author Orcid Image ;   Joachim Graf2 Author Orcid Image ;   Sara Y Brucker2 Author Orcid Image
Article Authors Cited by (28) Tweetations (12) Metrics

Markus Wallwiener   1 ;   Lina Matthies   1 ;   Elisabeth Simoes   2 ;   Lucia Keilmann   1 ;   Andreas D Hartkopf   3 ;   Alexander N Sokolov   2 ;   Christina B Walter   3 ;   Nina Sickenberger   1 ;   Stephanie Wallwiener   1 ;   Manuel Feisst   4 ;   Paul Gass   5 ;   Peter A Fasching   5 ;   Michael P Lux   5 ;   Diethelm Wallwiener   3 ;   Florin-Andrei Taran   3 ;   Joachim Rom   1 ;   Andreas Schneeweiss   1 ;   Joachim Graf   2 * ;   Sara Y Brucker   2 *

1 Gynecologic Oncology, National Center for Tumor Diseases, Hospital for General Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany

2 Research Institute for Women’s Health, Department of Women’s Health, University Hospital Tuebingen, Tuebingen, Germany

3 Department of Women’s Health, University Hospital Tuebingen, Tuebingen, Germany

4 Institute for Medical Biometry and Informatics, University Hospital Heidelberg, Heidelberg, Germany

5 Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany

*these authors contributed equally

Corresponding Author:

  • Markus Wallwiener
  • Gynecologic Oncology, National Center for Tumor Diseases, Hospital for General Obstetrics and Gynecology
  • University Hospital Heidelberg
  • Im Neuenheimer Feld 440
  • Heidelberg
  • Germany
  • Phone: 49 (0)6221563
  • Email: markus.wallwiener@gmail.com